cart-to-nk-cell-therapy_1920x400
Whitepaper

Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment

CAR Natural Killer cell therapy as a cancer treatment

Natural killer (NK) cell therapies use NK cells to detect and destroy target cells that cause disease, such as cancer cells. Modifying NK cells with Chimeric Antigen Receptors (CARs) offers a strategy for improving the clinical success of NK cell therapy.

Featured in this white paper:

  • NK cell background and cytotoxicity
  • CAR NK cell therapy description, including genetic modification and CAR generation
  • Advantages, limitations, and clinical progress of CAR NK cell therapy

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment

Download Whitepaper